These cancers make up some of the most common and most fatal diseases that women face, but despite this, gynaecological cancer is neither high profile, nor well funded.
One of our main aims is to fund locally based research into gynaecological cancers including ovarian, uterine, cervical and vulvar cancer, principally at the University of Surrey in Guildford, and within the Gynaeoncology Department.
GRACE has recently been accepted as an NIHR-partner charity. This means that some of our research projects are open to applicants through a competitive interview process. These projects undergo a strict peer review evaluation and are eligible for support from Clinical Research Network. The projects that are currently endorsed by CRN are listed below. Our next funding call will be announced in the next few months.
We also collaborate with research at many of the leading teaching and academic institutions around the UK and internationally.
This progressive approach supported by GRACE funding has led to many novel and cutting edge treatment developments for women facing gynaeacological cancer treatment in Surrey, Hampshire and Sussex.